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Abstract
Background: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and
uncontrolled high levels of unconjugated bilirubin lead to bilirubin-induced neurological damage and eventually
death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including
irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain.
Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which
molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo.
Methods: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the
response of the developing cerebellum to the bilirubin insult.
Results: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of
oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified
TNFα and NFKβ as key mediators of bilirubin-induced inflammatory response. Moreover, we reported that M1 type
microglia is increasingly activated during disease progression.
Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the
generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the
animals.
Conclusions: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with
ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential
intervention target to ameliorate neonatal lethality in Ugt1-/- mice.
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Background
Neonatal unconjugated hyperbilirubinemia is a common
condition occurring in more than 60% of term newborns
[1, 2] and almost all pre-term babies [3]. It is the result of
the increased bilirubin production, mainly due to the high
turnover of erythrocytes occurring after birth, and the de-
layed induction of the Ugt1a1 enzyme. It is usually consid-
ered a benign condition, but other concomitant causes
may lead to uncontrolled acute hyperbilirubinemia [4, 5].
Prolonged high bilirubin levels are life threatening and
often lead to permanent brain damage and death by ker-
nicterus [6].
The incidence of kernicterus increases in underdevel-
oped and developing countries [5], and death by kernic-
terus is ranked as one of the three top causes of death
among African newborns [7]. Clearly, the detailed identi-
fication of the neurological events and molecular targets
triggering bilirubin neurotoxicity will help the under-
standing and management of this disease. To this aim,
many in vitro and in vivo studies were carried out to in-
crease the understanding of bilirubin neurotoxicity (for a
review see [8]).
It has been shown that the free fraction of unbound
bilirubin (Bf) causes neurotoxicity in vivo, and that the
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decrease of Bf by albumin supplementation increases
neuro-protection and survival of the mutant mice and
rats [9, 10].
Several studies using primary culture of neurons, glia
cells or astrocytes, and neuronal-derived cell lines,
showed that the sensitivity to bilirubin differs among cell
types [11–14]. Moreover, bilirubin toxicity manifests in
particular brain developmental stages, with less differen-
tiated/immature neurons being more susceptible [15].
We showed in the Ugt1-/- mice that neurotoxicity is cell
specific, being the Purkinje cells (PCs) the most affected
neuron in the cerebellum [16–18].
By differential proteomic analysis of affected cerebella,
we showed that bilirubin affects antioxidant defences
reducing the overall capacity of neurons to tackle tox-
icity [18]. This observation was in line with in vitro ex-
periments using primary cultures of neurons [19] and
immortalized hepatoma cell lines [20, 21].
In addition, toxic levels of bilirubin induce an inflamma-
tory response through the release of pro-inflammatory cy-
tokines and the activation of MAPK pathway in astrocytes
and microglial cells primary cultures [22, 23], leading to
cell death. Moreover, high bilirubin levels induce oxidative
stress and activate the P38 MAPK pathway in vivo and in
vitro [18, 24, 25]. Likewise, in a Ugt1a humanized mouse
model, Yueh et al showed that glia activation and oxidative
stress are hallmarks of bilirubin-induced toxicity, being
Toll-like receptor 2 (TLR2) a key player of bilirubin-
mediated inflammatory response [26].
However, a time course study of the molecular
events leading to bilirubin neurotoxicity in vivo is still
missing. To this aim, we took advantage of the mouse
model of severe neonatal hyperbilirubinemia gener-
ated in our lab [16, 17]. Ugt1-/- mice reproduce the
major features of neonatal hyperbilirubinemia. In fact,
consequent to the absence of Ugt1a1 bilirubin-
glucuronidation activity in Ugt1-/- mice [16], total
plasma bilirubin levels rise immediately after birth
leading to important cerebellar damage, cerebellar hy-
poplasia and early death by kernicterus, with 50%
mortality at post-natal day 11 (P11) and no survivors
after P14 [17].
Using temporary phototherapy (PT) treatment during
the neonatal period, we identified a critical window of
neuronal susceptibility to bilirubin toxicity, correspond-
ing to post-natal day 8 [17]. We showed that the degree
of bilirubin damage correlates with the developmental
stage of the cerebellum, being the early phases the more
susceptible.
Based on the previous findings, in this study, we made
a step forward aiming to investigate the temporal pro-
gression of the molecular and cellular events leading to
bilirubin-induced neurodegeneration in the Ugt1-/-
mouse model of neonatal hyperbilirubinemia.
Methods
Animals
Mice were housed and handled according to institutional
guidelines, and experimental procedures approved by
the ICGEB board, with full respect to the EU Directive
2010/63/EU for animal experimentation. Ugt1-/- mice in
the FVB/NJ background have been generated previously
[17]. Homozygous mutant animals were obtained from
heterozygous mating. Male and female pups were used
for these studies. WT littermates were used as control.
Animals used in this study were at least 99.8% FVB/NJ
genetic background, obtained after more than ten back-
crosses with wild-type FVB/NJ mice. Mice were kept in
a temperature-controlled environment with 12/12-h
light/dark cycle. They received a standard chow diet and
water ad libitum.
Plasma bilirubin and UCB content measurement
Blood samples were collected at different time points in
mutant and WT littermates by decapitation in EDTA-
collecting tubes, at the moment of sacrificing the ani-
mals, as previously described [17]. Total bilirubin (TB)
determination in plasma was performed using Direct
and Total Bilirubin Reagent kit (BQ Kits, San Diego,
CA) adapting the method to use minimal volumes (10 μl
of plasma), as previously described [17].
Tissues for bilirubin content determination were col-
lected and analysed as previously described [27].
Preparation of total RNA from the mouse cerebellum and
real-time PCR analysis
Total RNA from mouse cerebellum was prepared using
EuroGOLD Trifast (Euroclone, Milano, Italy). One micro-
gram of total RNA was reverse-transcribed, as previously
described [18]. Total cDNA (1 μL) was used to perform
qPCR using the specific primers listed in Additional file 1.
qPCR was performed using the iQ SYBR Green Supermix
(Bio-Rad) and a C1000 Thermal Cycler CFX96 Real Time
System (Bio-Rad). Expression of the gene of interest was
normalized to the Gapdh housekeeping gene. Data were
analysed using the ΔΔCt method. All primers are listed in
Additional file 1.
Preparation of total protein extracts and western blot
analysis
Cerebella were dissected, homogenized in lysis solution
buffer (150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50
mM Tris HCl pH 8, 2× protease inhibitors) and analysed
by western blot as described previously [16]. Primary anti-
bodies used were as follows: anti-calbindin 1:2000 (Synap-
tic Systems, Goettingen, Germany), anti-NeuN 1:2000
(Millipore, Temecula, CA), anti-Glial Fibrillary acidic pro-
tein (GFAP) 1:1000 (Sigma, St. Louis, MO), anti-Iba1
1:1000 (Wako, Neuss, Germany), anti-cleaved caspase3
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1:500 (Cell Signalling), anti-caspase3 1:800 (Santa Cruz
Biotechnology), anti-CHOP 1:1000 (Santa Cruz, sc-56107),
anti-HO1 1:1000 (Enzo Life Sciences, ADI-OSA-110) and
anti-LC3 1:1000 (Sigma, L7543). Antibody anti-tubulin
mAb E7 (Developmental Studies Hybridoma Bank, Iowa
City, IA) or anti-Actin (Sigma, A2066) was used for loading
control determination. Representative images are shown in
the figures. Each timepoint was run in a separate gel.
Brain histology and immunofluorescence
Nissl staining and immunofluorescence analysis of cere-
bellum samples were performed as previously described
[17, 18]. The study was performed in a double-blind
fashion: the genotype of the animals was unknown to
the operator, while a different investigator analysed the
data. Measurements were averaged for each animal.
Briefly, after blocking, specimens were incubated with
the primary antibody for 2 h at RT in blocking solution
with anti-calbindin 1:400 (Synaptic Systems, Goettingen,
Germany), anti-NeuN 1:400 (Millipore, Temecula, CA),
anti-glial fibrillary acidic protein, GFAP 1:200 (Sigma, St.
Louis, MO), anti-iba1 1:200 (Wako, Neuss, Germany),
anti-TNFα 1:100 (sc-1350, Santa Cruz), anti-NFKβ 1:100
(sc-8008, Santa Cruz), anti-MRC1 1:100 (CD206 clone
MR5D3, MCA2235GA, BioRad), anti-CD68 1:100 (clone
FA-11, BioRad), anti-CHOP 1:100 (GADD153, sc-56107,
Santa Cruz), anti-HO1 1:200 (Enzo Life Sciences, ADI-
OSA-110), anti-Fas 1:100 (CD95, NB120-13550, Novus
Biologicals) and anti-HO1 1:200 (ADI-OSA-110, Enzo
Life Sciences). Antigen retrieval with sodium citrate pH6
was performed for CHOP and HO1 immuno-stainings
prior to blocking solution step. After 3× 5-min washes
with blocking solution, specimens were incubated with
secondary antibody (Alexa Fluor 488 or 568; Invitrogen
Carlsbad, CA) for 2 h at RT. Nuclei were visualized by
addition of Hoechst (10 μg/ml, Invitrogen) for 5 min
after secondary antibody solution. Nissl-stained sections
were mounted in Eukitt (Fluka, St. Louis, MO, USA)
while immunofluorescence (IF) slides were mounted in
Mowiol 4-88 (Sigma-Aldrich). Images were acquired on
a Nikon Eclipse E-800 epi-fluorescent microscope with a
charge-coupled device camera (DMX 1200 F; Nikon
Amstelveen, The Netherlands). Digital images were col-
lected using ACT-1 (Nikon) software.
Analysis of the layer thickness was performed on
Nissl-stained sections by measuring the layer depth (μm)
as previously described [16]. PC density analyses were
performed as previously described [16, 17].
Statistics
The Prism package (GraphPad Software, La Jolla, CA)
was used to analyse the data. Results are expressed as
mean ± S.D. Values of p < 0.05 were considered statisti-
cally significant. Depending on the experiment, Student’s
t test or two-way ANOVA, with Bonferroni’s post hoc
comparison tests, were used, as indicated in the legends
to the figures and text. Correlation analyses were done
using the Pearson coefficient to assess the linearity be-
tween two variables and calculate two-tailed p value
(95% of confidence interval).
Results
To better dissect the mechanisms leading to bilirubin
neurotoxicity, we analysed three sequential time points:
P5 at the onset of the pathology; P8 as a more advanced
pathological condition, in which lethality is partially re-
versible by phototherapy (PT) application in a low pro-
portion of mice [17]; and finally P10, as the latest and
most severe phase, just one day before reaching 50%
mortality [17].
Vulnerability to bilirubin depends on the developmental
stage and the neuronal cell type
We have previously reported that bilirubin induces
apoptosis in the cerebellum of C57Bl/6 Ugt1-/- mice at
P4 [18], a strain carrying the same genetic mutation but
showing a more severe phenotype [16]. Here, we used a
less severe mouse strain (Ugt1-/-/FVB/NJ) to study the
apoptotic pathway in the cerebellum, which is the most
vulnerable region to bilirubin toxicity in rodent animal
models (Fig. 1a) [17, 28, 29]. No increase in caspase 3
cleavage was observed at P5 (Fig. 1b), but apoptosis oc-
curred at P8, as demonstrated by a twofold increase of
activated caspase 3 (Fig. 1b). These results are in line
with our previous data showing that, despite some of the
mice were rescued from mortality by PT starting at P8,
the accumulated damage was not reversible [17].
Neurodegeneration is a well-known feature of bilirubin-
induced neurological dysfunction (BIND). To have a dee-
per insight in the mechanisms leading to cerebellar hypo-
plasia, we first estimated by western blot (WB) analysis
the levels of calbindin, a Purkinje cell (PC)-specific marker
[30]. We observed that PCs were not affected at P5, while
at P8 and P10, there was a significant reduction in calbin-
din levels in Ugt1-/- cerebellar protein extracts (56 and
61% decrease, at P8 and P10, respectively; Fig. 1c). Simi-
larly, IF analysis showed a reduction in PC number of 30
and 50% at P8 and P10, respectively, and the almost
complete disappearance of their dendritic arborization
(Fig. 1d).
Likewise, we assessed the degree of cerebellar damage
in brain sections of Ugt1-/- mice over the phases preced-
ing death (Fig. 1e and Additional file 2A). The long-term
exposure of cerebellar neurons to high levels of bilirubin
resulted in an overall reduction in cerebellar cortex
thickness of 20 and 32%, at P8 and P10, respectively
(Fig. 1e). Layer-thickness quantification showed that the
external germinal layer (EGL)- and molecular layer
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(ML)-thickness were significantly reduced at both P8
and P10, while the internal granular layer (IGL)-thick-
ness was reduced only at P10 (Additional file 2A).
Next, we verified whether bilirubin affected mature
cerebellar granule cells (GCs) by determining NeuN ex-
pression, a nuclear protein antigen whose expression in
the cerebellum is restricted to differentiated granule
neurons [31]. Western blot experiments showed that
bilirubin had no evident effects on differentiated GCs in
all time points analysed (Fig. 1f and Additional file 2B).
IF analysis performed at P8 and P10 showed no obvious
reduction in cell density of neurons located in the IGL
(Fig. 1g and Additional file 2C, respectively), suggesting
that differentiated GCs were not affected by chronic ex-
posure to bilirubin.
Collectively, our data support the concept that vulner-
ability of different neuronal cell types in vivo is associ-
ated with their developmental stage.
Then, we determined the levels of plasma and cerebel-
lar bilirubin at different time points, ranging from P2 to
P10 (Fig. 2). Mutant animals showed a time-dependent
increase in plasma bilirubin levels, associated to the
Fig. 1 Cerebellar neurons are differentially vulnerable to bilirubin. a Appearance of a jaundiced Ugt1-/- mouse (Ugt1-/-, red arrowed) and a wild-type (WT)
littermate at P8. b WB analysis of total cerebellum protein extract using anti-cleaved and anti-total caspase3 antibodies at P5 and P8 of WT and Ugt1-/-
mice. The bar graphs show the mean of cleaved/total caspase3 ratio of the bands. c WB analysis and quantification of total cerebellum protein extracts
of WT and Ugt1-/- mice using an anti-calbindin antibody at the indicated time points. d Representative fluorescent immunohistochemistry of cerebellar
sections from WT and Ugt1-/- mice at P8 and P10, using an anti-calbindin antibody (red) to highlight PCs. Hoechst (blue) was used to mark nuclei. Scale
bar 50 μm. The quantification of PC number at P8 and P10 of WT and Ugt1-/- mice is represented in the bar graph (cell/mm). e Left panel, Nissl staining of
cerebellar layers at P10 of WT and Ugt1-/- mice. Scale bar 100 μm. Right panel, layer depth quantification of P8 and P10 WT and Ugt1-/- (μm). f WB analysis
of total cerebellum protein extracts of WT and Ugt1-/- mice at P10 using an anti-NeuN antibody. g Representative fluorescent immunohistochemistry of
cerebellar sections from WT and Ugt1-/- mice using anti-NeuN antibody (green) to stain differentiated granule cells. Hoechst dye was used to stain nuclei
(blue). Scale bar 50 μm. For all the experiments, values represent mean ± SD. Student’s t test, *p< 0.05, **p < 0.01, ***p< 0.001. The number of WT and
Ugt1-/- was ≥3 in all the experiments and time points. For WB analysis, β-tubulin was used as loading control. EGL external germinal layer, IGL internal
granular layer, ML molecular layer
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worsening of the phenotype. Importantly, there was a
clear correlation between the levels of UCB in the cere-
bellum and those found in plasma (p < 0.001; Fig. 2f ).
These results demonstrate the tight association between
the accumulated levels of UCB in the cerebellum and
the increase in neurodegeneration and apoptosis.
Bilirubin induces macro- and micro-gliosis in the cerebel-
lum of Ugt1-/- mice
Since neurotoxicity is normally associated with neuroinflam-
mation [32, 33], we investigated whether bilirubin-induced
cell death was accompanied by an increase of inflammatory
markers in the cerebellum of the Ugt1-/- mice.
First, we analysed astrocyte response to bilirubin, by
determining glial fibrillary acidic protein (GFAP) levels,
an astrocyte-specific marker. No astrocytosis was de-
tected in the early time point of bilirubin exposure (P5,
Fig. 3a). Conversely, GFAP levels were two and threefold
increased at P8 and P10, respectively, as determined by
WB analysis (P8 and P10, Fig. 3a).
IF analysis performed at P8 and P10 revealed that the
glial scar was selectively localized in those cerebellar fis-
sures where PC loss was more prominent (Fig. 3b), such
as fissures IV to VIII (Additional file 3A, section of
whole cerebellum at P10). To note, the time-dependent
increase in GFAP protein levels was also evident at
mRNA level (Additional file 3B). These finding were in
good correlation with the time-dependent loss of PCs
(Fig. 1d).
Next, we determined the cerebellar microglia response
to bilirubin by the analysis of ionized calcium-binding
adapter molecule 1 (Iba1) as cell-specific marker. We
observed that bilirubin triggered an increase in Iba1
mRNA levels starting from P8, and reaching up to three-
fold increase at P10, as determined by real-time RT-PCR
(Additional file 4A). However, at protein levels, we
Fig. 2 Correlation analysis between total plasma bilirubin and cerebellar bilirubin content at different post-natal ages. Plasma total bilirubin (mg/dL)
and cerebellar UCB content (nmol/g) were plotted at each single time point: a P2, b P4, c P5, d P8 and e P10. f All time points in a single graph. Each
dot represents a single animal. Correlation analyses were done using the Pearson coefficient to assess the linearity between two variables and calculate
two-tailed p value (95% of confidence interval)
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observed a twofold increase in Iba1 only at P10 (Fig. 3c).
Furthermore, IF staining of cerebellar sections showed
that Iba1-positive cells were located in those zones more
affected by bilirubin (Fig. 3d and Additional file 4B).
Interestingly, among all the inflammation markers
tested (Fig. 4a and Additional file 5), only TNFα was
differentially expressed in mutant animals compared to
WT littermates, reaching up to ~10-fold (two-way
ANOVA, p < 0.05) in very severe conditions, such as
P10 (Fig. 4a). Immunofluorescence analysis of cerebel-
lar sections at P10 showed the presence of TNFα-
and NFKβ-positive cells in cerebellar samples from
mutant mice, which co-stained with microglia-positive
cells (Fig. 4b–d).
These data underline the complexity of the inflam-
matory response triggered by bilirubin in vivo and in-
dicate that neuroinflammation is an important player
contributing to each stage of the damage in our ex-
perimental model. Overall, these data show that the
inflammatory response in vivo increases over time as
bilirubin accumulates in the cerebellum and parallel
the onset of neurodegeneration.
Time-dependent decrease of M2 is inversely proportional
to M1 activation
To better characterize the microglia activation during
prolonged bilirubin exposure, we performed real-time
RT-PCR analysis of the molecular markers that discrim-
inate the activation of microglia/macrophage states, such
as those characterizing the pro-inflammatory M1 micro-
glia (CD68 and CD86) and the anti-inflammatory M2
microglia (MRC1, Arg1 and MRC2).
We observed that the messenger RNA (mRNA) of the
M1 pro-inflammatory microglia marker CD68 showed
2.0-, 2.5- and 4.0-fold increase at P5, P8 and P10, re-
spectively, compared to WT samples at the same time
points (Fig. 5a). Unexpectedly, when the mRNA expres-
sion of CD86, another component of M1 type microglia,
Fig. 3 Bilirubin neurotoxicity activates astrocytes and microglia cells. a WB analysis of total cerebellum protein extract using an anti-GFAP antibody at
indicated time points of WT and Ugt1-/- mice. b Representative fluorescent immunohistochemistry of cerebellar sections from WT and Ugt1-/- mice using
anti-GFAP antibody (red) to detect astrocytes, co-stained with an anti-calbindin antibody (green) to highlight PCs. Scale bar 50 μm. c WB analysis of total
cerebellum protein extracts using an anti-Iba1 antibody at P8 and P10 of WT and Ugt1-/- mice. d Representative fluorescent immunohistochemistry of
cerebellar sections from WT and Ugt1-/- mice using an anti-Iba1 antibody (green) to detect microglia, co-stained with an anti-GFAP antibody (red) to
highlight astrocytes. Scale bar 50 μm. For all the experiments, values represent the mean ± SD. Students t test, *p< 0.05. The number of WT and Ugt1-/-
was ≥3 in all the experiments and time points. For WB analysis, β-tubulin was used as loading control. For IF, Hoechst dye (blue) was used to mark nuclei
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was compared between Ugt1-/- mice and WT littermates,
no upregulation was observed.
By contrast, real-time RT-PCR analysis revealed an
inverted trend for the M2 type, which is considered to
compose the neuroprotective counterpart of microglia.
MRC1 mRNA in Ugt1-/- mice was upregulated at P5 and
showed decreased expression over time (the same pat-
tern was observed for Arg1, but differences were not sta-
tistically significant), while MRC2 was significantly
activated only at P8, and mRNA levels decreased at P10,
both in WT and Ugt1-/- cerebella (Fig. 5a).
IF experiments reinforced the findings obtained by
real-time PCR analysis showing MRC1-positive cells
at P5 (Fig. 5b), and of CD68 at P10 (Fig. 5c). In par-
ticular, a portion of MRC1-positive cells co-stained
with Iba1 at P5, confirming the activation of M2
microglia at the early stages of the disease. Likewise,
we reported an important increase in CD68-positive
cells at P10, providing evidence of pro-inflammatory
M1 type of microglia activation at the later stages of
the disease (Fig. 5c).
Since the transition from M2 to M1 phenotype is
generally associated with inflammation-induced path-
ologies, taken together these data indicate that
exposure to bilirubin triggers the activation of pro-
inflammatory microglia with a parallel decrease in the
neuroprotective one.
ER stress and oxidative stress activation in the early
stages
It has been shown that bilirubin is involved in endoplas-
mic reticulum (ER) stress response activation in in vitro
cell cultures [34–36]. Thus, we investigated whether ER
stress is a key event in the onset of bilirubin toxicity in
vivo.
Concomitantly to the activation of inflammation, we
observed that the bilirubin insult also triggered the acti-
vation of different ER stress markers during the early
phase of hyperbilirubinemia, as determined by real-time
RT-PCR analysis (Fig. 6a and Additional file 6A). mRNA
levels of ATF3, CD95/Fas and CHOP increased as aggra-
vating stages of bilirubin toxicity moved forward. Since
CHOP is a key effector in ER stress response, we per-
formed IF analysis of cerebellar sections at P5 and at
P10. IF analysis showed that CHOP signal was increased
in mutant mice compared to WT littermates in all cere-
bellar layers at P5 (external germinal layer, Purkinje cell
layer and internal granular layer, Fig. 6b).
Fig. 4 Inflammatory mediators of bilirubin neurotoxicity. a Relative mRNA expression of inflammatory markers. WT and Ugt1-/- mice mRNA cerebellar
expression levels of IL18, NFKβ, nNOS, MMP2, MMP9 and TNFα were analysed at the indicated time points by qRT-PCR. For each gene, data were
normalized according to the values of the WT samples at P5. For all the experiments, values represent the mean ± SD. Two-way ANOVA test, *p < 0.05.
The number of WT and Ugt1-/- was ≥3 in all the experiments and time points. b Representative IF of cerebellar sections from WT and Ugt1-/- mice at
P10 using an anti-TNFα antibody (green), co-stained with an anti-GFAP antibody (red) to highlight astrocytes. c Representative IF of cerebellar sections
at P10 using an anti-TNFα antibody (green), co-stained with an anti-Iba1 antibody (red) to highlight microglia. d Representative IF of cerebellar sections
at P10 using an anti-NFKβ antibody (red), co-stained with an anti-Iba1 antibody (green) to highlight microglia. Scale bar 50 μm. For IF, Hoechst dye
(blue) was used to mark nuclei
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As neurodegeneration moved forward, we observed that
Fas/CD95 and CHOP signal concentrated in the PCL
(Fig. 6c, d). In particular, at P10, CHOP was mainly local-
ized in the nucleus of severely neurodegenerated PCs, but
not in granule cell neurons (Fig. 6d and Additional file
6D). Moreover, we observed that CHOP-positive Purkinje
cells were surrounded by Iba1-positive cells (Fig. 6d, e and
Additional file 6E) indicating that microglia cells were ac-
tively engulfing degenerated neurons.
Finally, we focused our attention on oxidative stress,
which is considered a major process triggered by bili-
rubin in vivo [18]. By real-time RT-PCR, different
markers of oxidative stress were analysed to assess
their activation status (Fig. 7a and Additional file 7A-B).
We could not detect any variation in mRNA levels of the
analysed cytochrome P450 family 1 subfamily A member
2 (Cyp1a1), and cytochrome P450 family 2 subfamily A
member 5 (Cyp2a5) (Additional file 7B), nor in Nrf2, an
important transcription factor involved in cellular re-
sponse to oxidative stress (Fig. 7a). On the contrary, both
the mRNA and protein expression levels of HO1 (heme
oxygenase 1), a key enzyme in heme catabolism, were in-
creased in RNA and protein extracts from Ugt1-/- cere-
bella, in a time-dependent manner, starting from P8 and
reaching more than fourfold increase at P10 at protein
level (Fig. 7b). IF analysis showed an important increase of
HO1-positive cells in the Purkinje cell area (P5 and P10,
Additional file 7C and Fig. 7c, respectively). All HO1-
positive cells were also Iba1 positive, but not Calbindin or
NeuN positive, suggesting that some microglia cells expe-
rienced oxidative stress as a consequence of their phago-
cytic activity on degenerated PCs.
Autophagy is a late event triggered by bilirubin
Because of the close connection between oxidative
stress, neuro-apoptosis, inflammation and autophagy, we
Fig. 5 Bilirubin induces activation of M1 and M2 microglia. a Time course of mRNA expression levels of M1 and M2 microglia markers. WT and Ugt1-/-
mice mRNA cerebellar expression levels of CD68, CD86, MCR1, Arg1 and MCR2 were analysed at the indicated time points by qRT-PCR. For each gene, data
were normalized according to the values of the WT samples at P5. For all the experiments, values represent the mean ± SD. Two-way ANOVA test, *p<
0.05. The number of WT and Ugt1-/- was ≥3 in all the experiments and time points. b Representative IF of cerebellar sections from WT and Ugt1-/- mice at
P5 using an anti-MRC1 antibody (red) to detect M2 microglia, co-stained with an anti-Iba1 antibody (green) to highlight microglia. c Representative IF of
cerebellar sections at P10 using an anti-CD68 antibody (red) to detect M1 microglia, co-stained with an anti-Iba1 antibody (green). For IF, Hoechst dye (blue)
was used to mark nuclei. Scale bar 50 μm
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investigated whether the latter was activated in vivo in
response to bilirubin.
To determine whether autophagy is triggered by hyper-
bilirubinemia, we performed a WB analysis and quantified
the levels of the LC3-II form, as a marker of autophagy.
We observed the increase the LC3-II form only in cerebel-
lar total extracts of Ugt1-/- animals at P10 (Fig. 8), corre-
sponding to the most severe time point analysed.
These data showed, for the first time, that bilirubin
triggers autophagy in vivo in a mouse model of severe
neonatal hyperbilirubinemia.
Discussion
Unveiling the mechanisms operating at the onset of a
given disease is essential to develop potential pharmaco-
logical therapies against bilirubin-induced brain damage.
Our data indicate that long-term exposure of the de-
veloping cerebellum to high bilirubin levels induces the
concomitant activation of different mechanism, ranging
from inflammation to ER stress. In particular, we ob-
serve that the inflammatory response plus ER stress are
activated in the early stages of the disease onset and, in
turn, they affect survival of developing neurons. At last,
Fig. 6 ER stress response to sustained bilirubin levels. a Relative mRNA expression analysis of different genes to assess the ER stress response over
prolonged bilirubin exposure. WT and Ugt1-/- mice mRNA expression levels of ATF3, CHOP and CD95/Fas were analysed at indicated time points by qRT-
PCR. For each gene, data were normalized according to the values of the WT samples at P5. For all the experiments values represent the mean ± SD.
Two-way ANOVA test, *p < 0.05. The number of WT and Ugt1-/- was ≥3 in all the experiments and time points. b Representative IF of cerebellar sections
from WT and Ugt1-/- mice at P5 using an anti-CHOP antibody (red), co-stained with (left panel) an anti-calbindin antibody (green) to highlight Purkinje
cells or (right panel) anti-NeuN to highlight granule cells. c Representative IF of cerebellar sections at P10 using an anti-CD95/Fas antibody (green), an
anti-calbindin antibody (red) to highlight Purkinje cells. d Representative IF of cerebellar sections at P10 using an anti-CHOP antibody (red), co-stained
with (left panel) an anti-calbindin antibody (green) or (right panel) anti-Iba1 to highlight microglia. e Representative IF of cerebellar sections at P10 using
an anti-Calbindin antibody (red), co-stained with an anti-Iba1 antibody (green). For IF, Hoechst dye (blue) was used to mark nuclei. Scale bar 50 μm
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bilirubin-induced neurotoxicity stimulates the autophagy
pathway (Fig. 9a).
In the following sections, we will discuss in detail
the interplay between the major players identified in
the present work (Fig. 9b) and provide possible future
directions.
Oxidative stress response
Although mildly elevated bilirubin concentrations are
considered beneficial due to its antioxidant properties,
high levels of bilirubin lead to considerable oxidative
stress [37, 38]. This is particularly evident in the central
nervous system when ROS production overwhelms anti-
oxidant defences [39], resulting in neurodegeneration.
Typically, the redox-sensitive pathway is activated at
the onset of brain injury as a protection to overcome
oxidative stress. This was well demonstrated in tissue-
culture studies showing that UCB-induced ROS excess
impairs glutathione homeostasis [35, 40] and mitochon-
drial metabolism resulting in a cellular energetic crisis,
swelling, cytochrome c release [41] and calcium perturb-
ation [42]. All these events activate the mitochondrial
apoptotic pathway [43] leading to increased oxidative
stress and cellular redox status imbalance [44, 45]. Like-
wise, others and we showed that oxidative stress is a key
feature of neurotoxicity animal models of systemic
hyperbilirubinemia [18, 26, 46]. However, oxidative
stress response to bilirubin did not elicit the induction
of Cyps in our mouse model (Additional file 7B), differ-
ently to what observed in the Gunn rat [47], an animal
model of the disease presenting a milder phenotype.
Interestingly, in our mouse model, the increase in ROS
production resulted from the presence of activated micro-
glia cells in the region where Purkinje cells degenerate.
Fig. 7 Bilirubin-induced oxidative stress response. a Relative mRNA expression of different genes to assess the oxidative stress response. Expression levels
of Nrf2 and HO1 in WT and Ugt1-/- mice were analysed at P5, P8 and P10 by qRT-PCR. For each gene, data were normalized according to the values of the
WT samples at P5. Values represent the mean ± S.D. Two-way ANOVA test, **p< 0.01. The number of WT and Ugt1-/- was ≥3 in all the experiments and
time points. b WB analysis and quantification of total cerebellum protein extracts of WT and Ugt1-/- mice using an anti-HO1 antibody at the indicated time
points. Actin was used as loading control. Student’s t test, *p< 0.05, **p< 0.01. c Representative IF of cerebellar sections from WT and Ugt1-/- mice at P10
using an anti-HO1 antibody (red), co-stained with (left panel) an anti-calbindin antibody (green) to highlight Purkinje cells, (central panel) anti-NeuN antibody
to highlight granule cells or (right panel) anti-Iba1 antibody to highlight microglia. For IF, Hoechst dye (blue) was used to mark nuclei. Scale bar 50 μm
Fig. 8 Bilirubin triggers autophagy in the cerebellum of Ugt1-/- mice.
WB analysis of total cerebellum protein extracts using an anti-LC3
antibody at P5, P8 and P10 of WT and Ugt1-/- mice. β-tubulin was
used as a loading control. Lower panel: densitometric quantification
of the bands; results are expressed as the mean of the LC3 II/I ratio.
Student’s t test, ***p < 0.001. P5: WT n = 4, Ugt1-/- n = 4; P8: WT n = 4,
Ugt1-/- n = 4; P10: WT n = 3; Ugt1-/- n = 5
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These cells, which are positive for HO-1, are involved in the
removal of death cells and are associated with inflammation.
We observed that HO-1 expression levels increment over
time in the damaged tissue, with HO1-positive microglia
cells found as early as P5. This observation is in agreement
Silva and colleagues showing that an excess of activated
microglia produces high levels of nitric oxide, which in turn
mediates microglia-induced neuronal cell death [48].
ER stress response
The endoplasmic reticulum (ER) is very sensitive to per-
turbations of energy levels, intracellular calcium and
redox state. Important modifications of its balance result
in a condition named ER stress, characterized by an ex-
cess of unfolded proteins, and the induction of genes in-
volved in cell survival and protein degradation, aiming
to restore the normal state. However, when ER stress is
sustained for long periods of time, cells are unable to
overcome the accumulation of unfolded proteins and ac-
tivate the apoptotic pathway.
We report that mRNA levels of key ER stress markers,
such as ATF3 and Fas, were significantly induced in re-
sponse to high bilirubin levels. However, no changes in
transcriptional levels were observed in other genes re-
lated to unfolded protein response (UPR) and ER stress
(GPR78, GRP94, P58IPK, FKBP11 and DR5) at any time
point analysed (Additional file 6A). At the early stages of
the disease, CHOP signal was increased in cerebellar
sections of mutant mice, with more intense signal in the
Purkinje cell layer. At later stages, CHOP signal was lo-
calized in degenerating Purkinje cells, surrounded by
microglia Iba1-positive cells, suggesting their involve-
ment in removing cellular debris from death Purkinje
cells. These results are in agreement with previous find-
ings performed in tissue culture cell lines [20, 35, 36],
showing that CHOP and ATF3 are key mediators in ER-
stress bilirubin-induced response.
Interestingly, the increased expression of ATF3, Fas/
CD95 and CHOP genes indicates that cells sense the
overwhelming ER stress and activate the PERK-mediated
pathway [49, 50]. Since bilirubin levels continuously in-
crease over time [17], cells are not able to revert ER
stress and activate the apoptotic pathway, a hypothesis
supported by the increased levels of cleaved caspase 3
and TUNEL-positive cells observed in later stages of the
disease [17].
Altogether, these observations provide evidence that
ER stress is involved in the onset of bilirubin-induced
neuro-apoptosis of Purkinje cells in vivo.
PC neurodegeneration and neuro-apoptosis
The neurodegenerative phenotype in the cerebellum of
the mice used in this study is progressively enhanced after
sustained high levels of bilirubin and correlates well with
the reduced cerebellar development (Fig. 1e). Neurode-
generation is associated with reduced arborization of PC
and progressive cell loss (Fig. 1d). In contrast, mature
granule cells were not affected by bilirubin toxicity
(Fig. 1f). These results are in line with previous observa-
tions performed by our lab in the Ugt1-/- mouse model, in
both C57Bl/6 and FVB/NJ genetic backgrounds [16–18].
In particular, we have previously demonstrated that PCs
showed a neurodegenerative phenotype as determined by
Fig. 9 Molecular events leading to bilirubin neurodegeneration in a
mouse model of neonatal hyperbilirubinemia. a The three sequential
phases of the disease progression are indicated: P5, P8 and P10.
Representative cartoon showing the morphology of cerebellar sections
from WT (black line) and Ugt1-/- (red line). Bilirubin affects cerebellar size
of Ugt1-/- mice in a time-dependent manner. Boxes indicate the main
pathways and molecular players regulated by bilirubin. b Proposed
interplay between the molecular events leading to cerebellar
neurodegeneration. Exposure of the developing cerebellum to
toxic bilirubin levels triggers the activation of neuroinflammation, ER
stress, oxidative stress and autophagy pathways. Bold font indicates main
mechanisms involved in the onset of the disease; arrows and molecular
markers indicate the interconnection between different mechanisms. An
image of a neurodegenerated Purkinje neuron (stained with Calb1,
green) surrounded by glial scar (stained with GFAP, red) is represented
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FluoroJade positivity, TUNEL assay and Sholl analysis
[17, 18]. These data strengthen the concept that imma-
ture neurons are more sensitive to insults compared to
more differentiated ones [51] and that bilirubin affects
survival of neuronal precursors by impairing their neuro-
genesis, arborization and synaptic connectivity [17, 52].
Inflammation: pro-inflammatory mediators
In the nervous system, degenerating cells can stimulate
inflammation. Although most neurodegenerative dis-
eases involve inflammation, also ER stress is a critical
mechanism that can regulate inflammation and is linked
through several intersecting cellular pathways, particu-
larly those mediated by ROS [50].
We showed that NFKβ, a well-known inflammatory
mediator, responds to high bilirubin levels by the upreg-
ulation of its mRNA in a whole tissue extract and by its
increase in microglia cells which migrate to the site of
tissue injury, together with the increase of TNFα in
microglia and astrocytes. To this respect, NFKβ plays a
dual role because it exerts both neurotoxic and neuro-
protective functions depending on the kinetics and the
expression in the injured tissue. In fact, NFKβ regulates
the defence response to stress stimuli (inflammation and
oxidative stress) and cellular fate (apoptosis, proliferation
and differentiation). However, prolonged inflammation
leads to the activation of genes, mediated by NFKβ that
boosts oxidative stress, inflammation and apoptosis [50].
This is in line with our results showing the exacerbation
of neurotoxicity during the more severe conditions ob-
served at P10 (increase in HO1, caspase 3, astrocytosis
and gliosis). Similarly, NFKβ is activated in response to
pathological condition like trauma, ischemia or different
types of neurodegenerative disease [39].
Another key inflammatory factor is TNFα, activated in
the more severe phases of the pathology in the Ugt1-/-
pups. This factor is released by activated microglia and
astrocytes in the CNS and mediates the amplification of
neuroinflammation events and the initiation of the apop-
totic cascade. As in the cases of NFKβ, TNFα expression
is increased in many neurodegenerative conditions [53].
Our findings support previous data by the laboratory
of Brites and colleagues, showing that exposure of astro-
cytes and microglia primary cultures to bilirubin triggers
the release of the pro-inflammatory cytokines TNFα and
NFKβ [48, 54, 55]. However, in our model, increased
transcriptional levels of TNFα and NFKβ occur after ele-
vated and prolonged levels of tissue bilirubin, while in in
vitro cultures these events occur within hours upon bili-
rubin induction. In addition, other well-known pro-
inflammatory mediators are unchanged, such as IL1β,
IL6 and INFγ [56]. The discrepancy between in vitro and
in vivo data might be related to intensity of the insult,
interplay between different cell types and developmental
status of the brain, conditions not fully recapitulated by
in vitro primary cultures.
Inflammation: cellular mediators
Activated microglia and astrocytes are the main effectors
of the innate immune response in the CNS and are
strongly activated in response to neurodegeneration, re-
leasing neuroinflammatory factors. We showed that
hyperbilirubinemia triggers the activation of both astro-
cytes and microglia in the cerebellum of Ugt1-/- mice.
The activation of both astrocytes and microglia by
bilirubin has been reported both in vitro [57] and in
vivo. In particular, in vivo studies of Gunn rat cere-
bellum indicated that the increase in GFAP content is
a common trait of hyperbilirubinemia [58]. Moreover,
the involvement of glia and the role of TLR2 were
shown in the humanized knockout mouse model of
hyperbilirubinemia [26, 59], although the time course
of the disease onset was not investigated. The block
of inflammatory activation resulted in death of hyper-
bilirubinemic TLR2 KO mice, underlined the benefi-
cial effects of inflammatory response in the context of
bilirubin toxicity [26]. However, despite the important
inflammatory response observed in our Ugt1-/- ani-
mals, we could not detect TLR2 activation in re-
sponse to bilirubin (Additional file 5D). In fact,
because of the early neonatal lethality of our mouse
model, we investigated the developmental stages
within P5 and P10, while TLR2 activation was re-
ported at later stages, namely P14 [26]. We speculate
that the difference between the two models could be
related to the extent and duration of the bilirubin in-
sult, intrinsic differences between the two models, or
a combination of both.
In addition, we investigated the interplay between in-
flammatory M1 and anti-inflammatory M2 microglia in
the context of bilirubin toxicity. While M2 microglia
was induced in at the early stages of the disease, de-
creasing over time as the severity of the phenotype
increases, the trend of M1 microglia activation was the
opposite, being progressively activated at later stages, as
determined by Iba1 and CD68 M1 microglia markers. A
similar trend of activation/deactivation of M1 and M2
microglia was also observed in other neurodegenerative
pathologies such as spinal cord injury [60] and traumatic
brain injury [61, 62].
Autophagy: the deathblow
Increasing evidences showed that autophagy is a cru-
cial defence mechanism against neurodegenerative
diseases and its deregulation is a key event that de-
cides cell fate [63, 64].
Our results showed that autophagy is activated in re-
sponse to bilirubin in the cerebellum of the Ugt1-/- mice
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at P10 (Fig. 8). These observations are in line with ex-
periments performed in neuroblastoma and endothelial
cell lines exposed to high bilirubin levels [35, 65]. In
both cases, the autophagy pathway was activated at very
high levels of bilirubin (Bf = 100–140 nM) and at later
stages (24–72 h) when cell death was evident.
Interestingly, autophagy is linked to ER stress through
Fas/CD95, which is strongly induced in the cerebellum of
Ugt1-/- mice upon bilirubin exposure (Fig. 6). In fact, Fas/
CD95 triggers cell death by the induction of caspase-
mediated apoptosis but also stimulates autophagy through
MAPK pathway in HeLa cells [66]. Moreover, CHOP is re-
quired to increase transcriptional levels of genes responsible
for the correct formation and function of the autophago-
some [67].
Taken together, these results indicate that autophagy is
the latest pro-survival mechanism activated by cells to
overcome bilirubin cellular stress prior to death.
Conclusions
The dissection of the molecular mechanisms operat-
ing at the onset of neonatal hyperbilirubinemia re-
vealed that different pathways are simultaneously
regulated in response to the bilirubin insult, rather
than being activated in a sequential time frame. In-
flammation, together with ER stress, appear to be the
leading processes resulting in neurodegeneration. The
more precise understanding of the molecular interac-
tions is crucial to set up therapeutic strategies.
To this respect 4-phenylbutyrate (4-PBA), an ER stress
inhibitor, has been shown to reduce ER stress and
neurodegeneration in a mouse model of Parkinson’s
disease and tissue culture cells treated with bilirubin
[36, 68]. Moreover, minocycline, a tetracycline with
anti-inflammatory properties has been used in many
neurodegenerative diseases to reduce inflammation and
ameliorate the outcome of the disease [69], and in the
Gunn rat, it reduced cerebellar abnormalities [24]. Ad-
ministration of minocycline to juvenile Gunn rats re-
sulted in the prevention of acute brainstem auditory
evoked potential abnormalities produced by sulfadime-
thoxine [70, 71]. The concept that several components
participate in the response to bilirubin neurotoxicity is
supported by the observation that the treatment with
antioxidants of Gunn rats having sulfadimethoxine-
induced encephalopathy was not sufficient to reduce
BIND. On the contrary, minocycline, a molecule with
multiple properties in addition to the antioxidant effect,
was able to prevent BIND [46]. It remains to be tested
if the use of these compounds will ameliorate neurode-
generation and increase survival of the lethal mouse
model presented in this study.
Further studies are needed to demonstrated whether
modulation of one or more of them are required to
reduce neurodegeneration and death, before this know-
ledge could be translated to patients.
Additional files
Additional file 1: Table listing the oligonucleotides used. (XLSX 13 kb)
Additional file 2: A) Left panel, representative Nissl staining of cerebellar
layers at P8 of WT and Ugt1-/- mice. Right panel, layer depth quantification
(μm) at P8 and P10 of WT and Ugt1-/- mice. Scale bar 100 μm. B) WB
analysis of total cerebellum protein extracts using an anti-NeuN antibody at
P8. β-tubulin was used as a loading control. Values represent mean ±
SD. C) Representative fluorescent immunohistochemistry of cerebellar
sections from WT and Ugt1-/- mice using anti-NeuN antibody (green) to
stain differentiated granule cells at P8. Hoechst (blue) was used to mark
nuclei. Scale bar: 50 μm. For all the experiments the values represent
the mean ± SD. Student t test, ns not significant; *p < 0.05, **p < 0.01.
WT n = 4, Ugt1-/- n = 4. EGL, external germinal layer; IGL internal granular
layer; ML, molecular layer. (TIF 6110 kb)
Additional file 3: A) Representative fluorescent immunohistochemistry
of WT and Ugt1-/- cerebellum sections using anti-GFAP antibody (red) to
highlight astrocytes, co-stained with an anti-calbindin antibody (green) to
highlight PCs. Hoechst (blue) was used to mark nuclei. Scale bar: 500 μm.
Boxed areas indicate fields shown in Fig. 3b. IV, VI, VIb, VII and IX indicate
the cerebellar fissures. B) mRNA expression levels of GFAP at P5, P8 and
P10 in total RNA preparations of WT and Ugt1-/- cerebella. For each gene,
data were normalized according to the values of the WT samples at P5.
Values represent the mean ± S.D. Two-way ANOVA, **p < 0.01, ***p < 0.001.
Number of WT and Ugt1-/- was ≥3 in all the experiments. (TIF 11619 kb)
Additional file 4: A) mRNA expression levels of Iba1 at P5, P8 and P10
in total RNA preparations of WT and Ugt1-/- cerebella. For each gene,
data were normalized according to the values of the WT samples at P5.
Values represent the mean ± S.D. One-way ANOVA test, *p < 0.05. B)
Representative fluorescent immunohistochemistry of WT and Ugt1-/-
cerebellum using an anti-Iba1 antibody (green) to highlight microglia,
co-stained with an anti-GFAP antibody (red) to highlight astrocytes.
Hoechst (blue) was used to mark nuclei. Scale bar: 500 μm. Boxed areas
indicate fields shown in Fig. 3d. Number of WT and Ugt1-/- was ≥3 in all
the experiments. (TIF 10480 kb)
Additional file 5: A) Example of expression levels under the detection
limit of the technique. PCR product of IL1β mRNA expression. As positive
control dendritic cells (DC) were treated with LPS for 24 hs. (lane 2). B)
Example of detectable mRNA: TNFα expression. C) List of mRNAs that
were not detected by qRT-PCR in cerebellar total RNA extracts. D) TLR2
and E) iNOS mRNA relative expression levels in WT and Ugt1-/- animals at
the indicated time points. For each gene, data were normalized
according to the values of the WT samples at P5. Values represent
mean ± SD. Two-way ANOVA, ns not significant. For representative
agarose gels, lane 1: 1Kb ladder; lane 2: PCR product from dendritic
cells (DCs) treated with LPS for 24 h; lane 3: CB, Ugt1-/- cerebellar
total RNA extract; lane 4, blank. (TIF 2216 kb)
Additional file 6: A) Relative mRNA expression of ER stress response
genes showing no changes at the different time points. For each gene,
data were normalized according to the values of the WT samples at P5.
Values represent the mean ± S.D. Two-way ANOVA, ns not significant.
Number of WT and Ugt1-/- was ≥3 in all the experiments B) WB analysis
and quantification of total cerebellum protein extracts of WT and Ugt1-/-
mice using an anti-CHOP antibody at the indicated time points. Actin
was used as loading control. Student t test, ns not significant. C)
Representative IF of cerebellar sections from Ugt1-/- mice at P10 using
an anti-CHOP antibody (red), co-stained with an anti-calbindin antibody
(green) to highlight Purkinje cells; D) representative IF of cerebellar
sections from WT and Ugt1-/- mice at P10 using an anti-CHOP antibody
(red), co-stained with an anti-NeuN antibody to highlight granule cells;
E) representative IF of cerebellar sections from Ugt1-/- mice at P10 using
an anti-CHOP antibody (red), co-stained with an anti-Iba1 antibody to
highlight microglia. For IF, Hoechst dye (blue) was used to mark nuclei.
Scale bar: 50 μm. (TIF 24031 kb)
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Additional file 7: Relative mRNA expression of A) oxidative stress
response genes and B) Cyp1a1 and Cyp2a5 showing no changes at the
different time points. For each gene, data were normalized according to
the values of the WT samples at P5. Values represent the mean ± S.D.
Two-way ANOVA, ns not significant. Number of WT and Ugt1-/- was ≥3 in
all the experiments. C) Representative IF of cerebellar sections from WT
and Ugt1-/- mice at P5 using an anti-HO1 antibody (red), co-stained with
anti-Iba1 antibody to highlight microglia. For IF, Hoechst dye (blue) was
used to mark nuclei. Scale bar: 50 μm. (TIF 10064 kb)
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